| 216078 |
FRONTIERS IN MICROBIOLOGY |
Whole genome investigation of a divergent clade of the pathogen Streptococcus suis |
2015-11-04 |
10.3389/fmicb.2015.01191 |
Baig Abiyad, Weinert Lucy A., Peters Sarah E., Howell Kate J., Chaudhuri Roy R., Wang Jinhong, Holden Matthew T. G., Parkhill Julian, Langford Paul R., Rycroft Andrew N., Wren Brendan W., Tucker Alexander W., Maskell Duncan J. |
| 216077 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer |
2015-11-04 |
10.1186/2051-1426-3-s2-p112 |
Ziai James, Gilbert Houston, Foreman Oded, Eastham-Anderson Jeffrey, Chu Felix, Huseni Mahrukh, Kim Jeong M |
| 216076 |
ONCOLOGY LETTERS |
Overexpression of MCPH1 inhibits uncontrolled cell growth by promoting cell apoptosis and arresting the cell cycle in S and G2/M phase in lung cancer cells |
2015-11-04 |
10.3892/ol.2015.3857 |
ZHOU LIMIN, BAI YANJIE, LI YANXI, LIU XUELIANG, TAN TAO, MENG SHASHA, HE WENTING, WU XIAOBIN, DONG ZHIFANG |
| 216075 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure |
2015-11-04 |
10.1186/2051-1426-3-s2-p311 |
Shin Daniel, Garcia-Diaz Angel, Zaretsky Jesse, Escuin-Ordinas Helena, Hu-Lieskovan Siwen, Palaskas Nicolaos J, Hugo Willy, Komenan Marie Sara, Chmielowski Bartosz, Cherry Grace, Berent-Maoz Beata, Graeber Thomas G, Lo Roger, Comin-Anduix Begonya, Ribas Antoni |
| 216074 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Complete metastasectomy after high-dose interleukin-2 (HD IL-2) therapy for melanoma |
2015-11-04 |
10.1186/2051-1426-3-s2-p130 |
Chu Melinda, Hsueh Eddy, Richart John |
| 216073 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma |
2015-11-04 |
10.1186/2051-1426-3-s2-p114 |
Brown Christine E, Starr Renate, Aguilar Brenda, Brito Alfonso, Chang Brenda, Sarkissian Aniee, Weng Lihong, Jensen Michael, Barish Michael E, Badie Behnam, Forman Stephen J |
| 216072 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
2015-11-04 |
10.1186/2051-1426-3-s2-p438 |
Karlsson-Parra Alex, Laurell Anna, Lönnemark Maria, Brekkan Einar, Wallgren AnnaCarin, Magnusson Anders |
| 216071 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors |
2015-11-04 |
10.1186/2051-1426-3-s2-p175 |
Triozzi Pierre, Kooshki Mitra, Alistar Angela, Bitting Rhonda, Neal Amy, Lametschwandtner Guenther, Loibner Hans |
| 216070 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune monitoring in patients with colorectal cancer stage II |
2015-11-04 |
10.1186/2051-1426-3-s2-p266 |
Zavadova Eva, Vocka Michal, Spacek Jan, Francis Nicole, Konopasek Bohuslav, Fucikova Terezie, Skalova Helena, Dundr Pavel, Petruzelka Lubos, Rau Tilman T, Geppert Carol, Hartmann Arndt |
| 216069 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen encoded by an alternative ITGB2 transcript |
2015-11-04 |
10.1186/2051-1426-3-s2-p285 |
Pont Margot J, van der Lee Dyantha, van der Meijden Edith, van Bergen Cornelis, Kester Michel, Honders Maria, Vermaat Martijn, Eefting Matthias, Marijt Erik, Kielbasa Szymon, 't Hoen Peter-Bram, Falkenburg Frederik, Griffioen Marieke |
